Management & Directors
Tom Burnell: Chief Executive Officer
Mr. Burnell, age 55, is a senior executive with over 25 years of experience in the healthcare and veterinary marketplaces. In both staff positions, and under consulting agreements, Mr. Burnell has held numerous leadership roles. Mr. Burnell was the President of Boston Heart Diagnostics from July 2016 until March 2017, and he served as Operating Partner of Ampersand Capital Partners (“Ampersand”), a private-equity company, from January 2014 until December 2016, where he represented Ampersand’s investment in Elite One Source Nutrisciences, Inc. From October 2014 until May 2016, Mr. Burnell served as Executive Chairman of Accuratus Lab Services, Inc, and from November 2009 until November 2014 he was President and Chief Executive Officer of Viracor-IBT Laboratories, Inc. From September 2012 until December 2014, Mr. Burnell was President and Chief Executive Officer of Nebraska Heart Hospital, and from September 2006 until September 2011, he was President and Chief Executive Officer of Eurofins Scientific, Inc, a publicly held company trading on the Euronex Exchange. From June 2002 until September 2006, he was President and Chief Executive Officer of GenomicFX, Inc., a leader in livestock and aquaculture genomics. In addition, from September 2000 until June 2002, Mr. Burnell held various senior management positions at ContiGroup Companies, Inc., a global agriculture, food and nutrition company. Mr. Burnell holds a PhD in Nutrition from the University of Kentucky and a BS and MS in animal sciences from the University of Nebraska-Lincoln.
Louis Deluca: Chief Operations Officer
Louis Deluca, age 58, is the COO of True Nature Holding, Inc. Mr. Deluca served as VP of Operations for Mondetta US, Inc. – an online apparel designer and retailer – from 2015 to 2016. From 2012 to 2015, he served as the COO of The Ivory Company, a multichannel home décor retailer based in Atlanta, GA. From 2007 to present, Mr. Deluca was the Founder and CEO of Marietta Sign Company, a manufacturer and designer of customer signage based in Atlanta, GA. From 1981 to 2007, he served as Director of Inventory Planning and Sourcing for The Home Depot. He received a Technical Drafting Certificate from Gwinnett Technical College in 1977 and studied Business Management at the University of Phoenix.
Dr. Jordan Balencic, D.O.: Chairman of the Board of Directors
Dr. Jordan Balencic, D.O. age 30, is a physician entrepreneur and founder of businesses in the telemedicine, marketing and web services, and healthcare product development areas. Dr. Balencic completed his Internal Medicine Residency training at Pennsylvania State University, obtained his Medical Doctoral degree at Lake Erie College of Osteopathic Medicine, and earned his B.S. in Biology from Gannon University. He belongs to numerous professional organizations, and serves the Veterans Administration as a primary care physician.
James Czirr: Director
Mr. James Czirr, age 62, is most recently involved with Galectin Therapeutics, Inc. (NASDAQ:GALT). He served as Chairman of the Board for Galectin from February 2009, and Executive Chairman from February 2010 until January 2016. He now sits on the Board as the representative for their Series B Preferred holders. He is a co-founder of 10X Fund, L.P. and is a managing member of 10X Capital Management LLC, the general partner of 10X Fund, L.P. Mr. Czirr was a co-founder of Galectin Therapeutics in July 2000. Mr. Czirr was instrumental in the early stage development of Safe Science Inc., a developer of anti-cancer drugs; served from 2005 to 2008 as CEO of Minerva Biotechnologies Corporation, a developer of nano particle bio chips to determine the cause of solid tumors; and was a consultant to Metalline Mining Company Inc., now known as Silver Bull Resources, Inc., (AMEX: SVBL), a mineral exploration company seeking to become a low-cost producer of zinc. Mr. Czirr received a B.B.A. degree from the University of Michigan.
ADVISORY BOARD MEMBERS:
On September 28, 2016, the Board agreed to create a non-executive, non-governance Advisory Board and appoint individuals who have technical skills in the healthcare and pharmacy area, and who can advise the Company. These are non-operational roles, and are not subject to the requirements of Section 16 of the Securities Act. Their compensation shall be the issuance of 100,000 shares of restricted common stock for the next 12 months of service.
- Dr. James G. McMurray, M.D., age 75, is an early investor in the True Nature Holding, Inc. and a 40+ year practicing Urologist located in Huntsville, AL, where he is Medical Director and Principal Investigator of Urology for the Medical Affiliated Research Center (http://www.marc-research.com), an independent clinical research entity funded by pharmaceutical companies. He is an AUA Board Certified Urologist who has led numerous trials associated with urology.
- Phillip Giordano, age 57, is the owner of a compounding pharmacy in Boca Raton, Florida which specializes in both veterinary medicine as well as specialized human medications. He is a licensed pharmacist, and has advised the Company since the formation of Newco4pharmacy, LLC, which was acquired by the Company in 2015. Previously as Director of Pharmacy Services in Pompano Beach, Florida, he was responsible for sales and distribution of all internet related prescription sales in 16 states, and internationally.
- C. Leo Smith, age 48, is the former Chairman of the Board of Directors and former Chief Executive and Chief Financial Officer of several private and U.S. public companies He is mostly focused on Mergers and Acquisitions and consolidating small private companies into larger public companies that will bring value and strong dividends to its investors, and shareholder base. Mr. Smith is very active both in the private and public sector and continuously is looking to build and grow small private entities into larger Multinational companies. His experience is diverse in many areas of business, for example: manufacturing, pharmaceutical distribution, service industry, international consulting, staffing, and most recently expanding into direct retail.